What Researchers Did
Researchers evaluated the effect of hyperbaric oxygen delivery on retinal photoreceptors in 48 subjects with retinitis pigmentosa, comparing an HBO-treated group to a control group over two years.
What They Found
In the hyperbaric oxygen group, electroretinographic mean values significantly increased from 4.68 microV at baseline to 14.4 microV after two years (p<0.001). Conversely, the control group experienced a decrease in mean values from 4.92 microV at baseline to 2.97 microV at the study's end (p<0.02).
What This Means for Canadian Patients
This study suggests that hyperbaric oxygen therapy could potentially help rescue retinal photoreceptors and slow the progression of retinitis pigmentosa. If confirmed by larger studies, this treatment might offer a new avenue for preserving vision in Canadian patients affected by this degenerative eye condition.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it involve Canadian researchers or patients.
Study Limitations
The study involved a relatively small number of participants and the abstract did not fully detail all potential limitations.